Dynamic diversity of the tryptophan pathway in chlamydiae: reductive evolution and a novel operon for tryptophan recapture by Xie, Gary et al.
City University of New York (CUNY)
CUNY Academic Works
Publications and Research City College of New York
August 2002
Dynamic diversity of the tryptophan pathway in
chlamydiae: reductive evolution and a novel
operon for tryptophan recapture
Gary Xie
University of Florida
Carol A. Bonner
Los Alamos National Laboratory
Roy A. Jensen
CUNY City College
How does access to this work benefit you? Let us know!
Follow this and additional works at: http://academicworks.cuny.edu/cc_pubs
This Article is brought to you for free and open access by the City College of New York at CUNY Academic Works. It has been accepted for inclusion in
Publications and Research by an authorized administrator of CUNY Academic Works. For more information, please contact
AcademicWorks@cuny.edu.
Recommended Citation
Xie, G., Bonner, C. A. & Jensen, R. A. (2002). Dynamic diversity of the tryptophan pathway in chlamydiae: reductive evolution and a
novel operon for tryptophan recapture. , 3(9), research0051.1-research0051.17. doi:.
http://genomebiology.com/2002/3/9/research/0051.1
co
m
m
ent
review
s
repo
rts
depo
sited research
interactio
ns
info
rm
atio
n
refereed research
Research
Dynamic diversity of the tryptophan pathway in chlamydiae:
reductive evolution and a novel operon for tryptophan recapture
Gary Xie*†, Carol A Bonner† and Roy A Jensen*†‡
Addresses: *Department of Microbiology and Cell Science, Gainesville, FL 32611, USA. †BioScience Division, Los Alamos National
Laboratory, Los Alamos, NMo 87544, USA. ‡Department of Chemistry, City College of New York, New York, NY 10031, USA.
Correspondence: Roy A Jensen. E-mail: rjensen@ufl.edu
Abstract
Background: Complete genomic sequences of closely related organisms, such as the
chlamydiae, afford the opportunity to assess significant strain differences against a background of
many shared characteristics. The chlamydiae are ubiquitous intracellular parasites that are
important pathogens of humans and other organisms. Tryptophan limitation caused by
production of interferon- by the host and subsequent induction of indoleamine dioxygenase is a
key aspect of the host-parasite interaction. It appears that the chlamydiae have learned to
recognize tryptophan depletion as a signal for developmental remodeling. The consequent non-
cultivable state of persistence can be increasingly equated to chronic disease conditions.
Results: The genes encoding enzymes of tryptophan biosynthesis were the focal point of this
study. Chlamydophila psittaci was found to possess a compact operon containing PRPP synthase,
kynureninase, and genes encoding all but the first step of tryptophan biosynthesis. All but one of
the genes exhibited translational coupling. Other chlamydiae (Chlamydia trachomatis, C. muridarum
and Chlamydophila pneumoniae) lack genes encoding PRPP synthase, kynureninase, and either lack
tryptophan-pathway genes altogether or exhibit various stages of reductive loss. The origin of the
genes comprising the trp operon does not seem to have been from lateral gene transfer.
Conclusions: The factors that accommodate the transition of different chlamydial species to the
persistent (chronic) state of pathogenesis include marked differences in strategies deployed to
obtain tryptophan from host resources. C. psittaci appears to have a novel mechanism for
intercepting an early intermediate of tryptophan catabolism and recycling it back to tryptophan.
In effect, a host-parasite metabolic mosaic has evolved for tryptophan recycling.
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Background 
Chlamydiae are obligate intracellular pathogens that infect a
variety of host organisms and exhibit individual tissue tropisms
within a host species. The availability of complete genomic
sequences for different species has provided a contemporary
impetus for research to uncover specific relationships of
chlamydial genes with the disease process, an impetus that is
particularly welcome because the fastidious growth require-
ments of the organism have made it relatively intractable to
experimentation. A number of analyses dealing with the
comparative genomics of the chlamydiae have appeared in
the recent literature [1-3]. 
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Chlamydiae all progress through a life cycle that is inti-
mately tied to success as a pathogen. The host is invaded by
elementary bodies (EBs), which represent the extracellular
infectious stage. The newly established EBs develop into
intracellular reticulate bodies (RBs) that replicate in antici-
pation of maturation to EBs, which then lyse the host cell
and initiate a new round of pathogen proliferation. Aggres-
sive progress through repetitions of this cycle characterizes
the acute disease process. Distinct changes in cell size, chro-
matin organization, membrane characteristics and meta-
bolic competence constitute endpoints of a reversible
developmental profile. A third metabolic stage called persis-
tence is increasingly recognized to attend the chronic disease
process [4]. The persistent state can be induced in vitro in
tissue culture in response to various environmental cues
such as nutrient limitation, antibiotic treatment or presence
of interferon- (IFN-) [5,6]. All of the latter may act to
trigger persistence by eliciting a degree of metabolic starva-
tion [7]. In fact, it has been shown [7] that even normal
blood plasma concentrations of amino acids are sufficiently
limiting to infected cell cultures to promote the persistent
state. Cells present in the persistent state have been detected
in vivo, for example, in the synovial membranes of patients
with Chlamydia-associated reactive arthritis [8]. Chlamydial
cells poised in this state of metabolic latency exist as viable
but non-cultivable cells that are ‘abnormally’ enlarged and
which exhibit distinctive morphological characteristics [4].
One of the most prominent host protective responses to
chlamydial infections has been the production of the T-cell-
derived pro-inflammatory cytokine IFN-. This cytokine
induces a variety of biochemical changes in host metabolism,
apparently designed to thwart the ability of intracellular
parasites to gain access to host resources. Relative sensitivity
to IFN- varies, with C. muridarum and C. psittaci being
relatively resistant compared to C. pneumoniae and the
various C. trachomatis serovars. The relative insensitivity in
vivo of C. muridarum, compared to human strains of C. tra-
chomatis, is supported by the results of Cotter et al. [9] and
Perry et al. [10]. Conflicts in the literature about the sensitiv-
ities of C. trachomatis and C. muridarum isolates to IFN--
mediated inhibition have been attributed to strain variation
[10]. A well documented effect of IFN- has been its ability
to decrease the availability of L-tryptophan in host cells.
(Other anti-chlamydial effects involve the inducible synthe-
sis of nitric oxide and deprivation of iron [11].) Although
effective L-tryptophan starvation may resolve an acute infec-
tion, a more modulated degree of starvation for L-tryptophan
is thought to be intimately involved in the phenomenon of
persistence [12]. Thus, tryptophan limitation is increasingly
recognized as an important factor in a variety of chronic
disease conditions. As initially shown by Byrne et al. [13,14]
and confirmed by others [15,16], IFN- acts by inducing
indoleamine 2,3-dioxygenase, a host enzyme that converts L-
tryptophan to L-formylkynurenine. (This broad-specificity
monomeric enzyme is different from the non-homologous
tryptophan 2,3-dioxygenase in liver [17] and brain tissues
[18].) In addition, IFN- is a potent inducer of host trypto-
phanyl-tRNA synthetase [19]. Thus, the host not only
decreases the pool of tryptophan available to intracellular
parasites, but the remaining tryptophan molecules tend to
be increasingly sequestered by the elevated level of host
tryptophanyl-tRNA synthetase. 
The biological relationship of IFN-, indoleamine dioxygenase,
tryptophan limitation and the persistent state of intracellu-
lar parasitism extends beyond chlamydial parasites, as illus-
trated by consideration of Toxoplasma gondii [20]. This
unicellular protozoan is a eukaryotic intracellular parasite
that is subject to tryptophan limitation by exactly the same
host mechanism used against the chlamydiae. The result is a
generally widespread and asymptomatic state of chronic
infection. Even extracellular bacteria such as group B
streptococci (tryptophan auxotrophs) are inhibited by the
IFN- mechanism of tryptophan limitation [21]. In this
context, it may be no accident that pathogens such as Ente-
rococcus faecalis, Haemophilus ducreyi, Clostridium diffi-
cile and Cl. perfringens are conspicuous tryptophan
auxotrophs that maintain full competence for phenylalanine
and tyrosine biosynthesis. The broad biological impact of
host tryptophan catabolism is further illustrated by the
hypothesis that tryptophan catabolism localized in placental
tissue provides a mechanism (suppression of lymphocyte
proliferation [22]) to prevent immune rejection of the mam-
malian fetus [23]. An additional example of the far-reaching
consequences of host tryptophan catabolism is illustrated by
the potential for persistent immune activation to disrupt the
balance between serotonin and kynurenine production from
tryptophan, thus linking the immunological network and
neuropsychiatric consequences of serotonin imbalance [24].
Results and discussion 
Dynamic gene reorganization and gene flux within the
chlamydial plasticity zones 
Figure 1 shows the gene organization in C. psittaci of trypto-
phan-pathway genes (trp), the large toxin gene lifA, a per-
forin-family gene, and a conserved hypothetical gene that is
specific to the C. pneumoniae/C. psittaci lineage. lifA, the
trp genes, the perforin-encoding gene and a few other genes
can be generally recognized as interspecies residents of a
‘plasticity zone’ located near the terminus of replication [2].
As Read et al. [2] pointed out, dynamic events of gene shuf-
fling, gene insertion and gene loss are apparent within this
plasticity zone. They discussed the lack of variation in GC
content and the absence of evidence for gene transfer, as
well as the variation of tryptophan-pathway genes. 
Substantial variation is also striking with respect to lifA.
C. psittaci possesses a single copy of lifA, C. muridarum has
three paralog copies, C. trachomatis has a single pseudogene
with frameshift mutations and C. pneumoniae lacks lifA
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altogether. lifA (lymphocyte inhibitory factor) encodes a
large toxin that can block production of IFN-. It therefore
undermines the host’s ability to deplete tryptophan through
induction of indoleamine dioxygenase. lifA is of limited
phylogenetic distribution, being present elsewhere only in
enteropathogenic strains of Escherichia coli [25]. The effect
of IFN- is dose-dependent [26,27], and different concentra-
tion ranges have been shown [28] to allow rapid progress
through the acute infection cycle (low IFN- concentration),
to promote a stable state of persistence (medium IFN- con-
centration), or to completely resolve the infection (high IFN-
 concentration). Thus, to the extent that lifA is considered
to be a factor, C. muridarum presumably has a maximal
capability to block induction of IFN-, whereas C. psittaci
has only a partial ability to block IFN- induction via lifA.
The amino-terminal portion of lifA (which includes the
remnant of lifA remaining in C. trachomatis) is homologous
to the gene encoding a clostridial toxin, and Belland et al.
[29] have recently demonstrated cytotoxic activities in
C. muridarum and C. trachomatis D that are indistinguish-
able from those mediated by clostridial toxin B. Cytotoxicity
was dose dependent with respect to lifA copy number.
Belland et al. [29] note that if the chlamydial cytotoxin
inhibits lymphocyte activation (as does LifA in E. coli), it
would provide a mechanism for immune evasion. 
Within the plasticity zone shown in Figure 1, C. psittaci has
an operon arrangement of genes encoding a nearly complete
pathway of tryptophan biosynthesis. In contrast, the plastic-
ity zone of C. trachomatis has only two structural genes of
tryptophan biosynthesis (trpEb and trpEa), and C. muri-
darum has no tryptophan-pathway genes at all [2]. In addi-
tion, both C. trachomatis and C. muridarum have a trpC
gene outside of the plasticity zone. C. pneumoniae has no
tryptophan-pathway genes present anywhere in the genome.
Novelty of the tryptophan operon of C. psittaci
The pathway of tryptophan biosynthesis consists of five
steps, and we have used the convention [30] of naming the
genes in the order of the steps, trpA, trpB, trpC, trpD and
trpE. The  and  subunits of trpA are named trpAa and
trpAb, and the  and  subunits of trpE are named trpEa
and trpEb. This nomenclature is logical, easy to remember
and suited to the modern era of comparative genomics,
where gene naming needs to be consistent and to correspond
to proteins at the level of catalytic domain (subunit). Thus,
trpAaAbBCDEaEb corresponds to the conventional E. coli
designations of trpEGDFCAB. 
The tryptophan operon in C. psittaci is incomplete in that
genes encoding the two subunits of anthranilate synthase
(trpAa and trpAb) are absent. These genes are not present
elsewhere in the genome. Hence, no biochemical connection
with chorismate as a beginning substrate for tryptophan
biosynthesis is apparent (Figure 2). The tryptophan operon
of C. psittaci exhibits further striking aspects of novelty. Not
only does it contain genes (kynU and kprS) that are not
components of the classical tryptophan operon, but these
genes are not even present in other chlamydiae. kynU
encoding kynureninase and kprS (alternative name: prsA)
encoding PRPP synthase are located at the 3´  end of the
C. psittaci trp operon (see Figure 1). These genes, together
with trpB, trpD, trpC, trpEb and trpEa, comprise a compact
operon in which all but one gene overlaps its neighbor in the
operon (translational coupling). A regulatory gene, the trpR
repressor, precedes the tryptophan operon on the amino-
terminal side. A second paralog of the tryptophan synthase 
subunit (trpEb-2) is also present in an extra-operonic loca-
tion several genes upstream of trpR. The possible functional
significance of this paralog as serine deaminase has been
discussed elsewhere [30].
Figure 1
The tryptophan-recapture operon of Chlamydophila psittaci (Cps). Genes are color-coded as shown in the key. Arrows indicate the direction of
transcription. The nomenclature for tryptophan-pathway genes is that elaborated by Xie et al. [30], whereby genes encoding the five enzymes are named
in order of the pathway steps. The two subunits of the first and fifth steps are given additional lower-case identifiers, that is, trpAa/trpAb and trpEa and
trpEb (for simplicity, the trp genes are labeled without the trp identifier). Nucleotide spacing between genes is shown; negative values indicate open
reading frames that overlap (translational coupling). The membrane-attack complex/perforin family protein from the chlamydiae, which belongs to PFAM
protein family HMM PFO1823, has been discussed by Ponting [59]. The gene encoding this protein in C. psittaci appears to have multiple frameshifts, a
possible carboxy-terminal truncation, and a possible insertion. Whether sequencing errors might account for this is unknown at the present time.
Cpn, Chlamydophila pneumoniae. 
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Tryptophan-pathway genes
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Membrane-attack complex/perforin family
Hypothetical protein specific for Cps and Cpn
Host-parasite metabolic mosaic for tryptophan
cycling 
A rationale for inclusion of kprS and kynU in the C. psittaci
tryptophan operon can be visualized from an examination of
Figure 2. The ability of C. psittaci to synthesize L-tryptophan
requires an alternative source of anthranilate (other than
chorismate) as C. psittaci lacks anthranilate synthase.
Kynurenine, intercepted from the host stream of catabolism,
would satisfy this requirement given the presence of KynU.
PRPP input is required for the TrpB-catalyzed step, and thus
it was necessary for C. psittaci to recruit PRPP synthase
(kprS) to the operon. The import of ATP (substrate for PRPP
synthase) from the host is also probably needed, and the
presence of ATP translocases in chlamydial genomes has
been documented [1-3]. Alternative sources of ATP, for
example, utilization of PEP by pyruvate kinase, are not alto-
gether ruled out [31]. Finally, serine import is required for
the tryptophan synthase step as chlamydiae are not compe-
tent for serine biosynthesis. 
Figure 2 illustrates the mammalian ‘kynurenine’ pathway of
tryptophan catabolism, which is prominent in liver and
kidney. The initial step is rate limiting and is catalyzed by
either of two enzymes: indoleamine 2,3-dioxygenase or tryp-
tophan 2,3-dioxygenase. The latter is the true catabolic
entity, has narrow specificity for tryptophan, and is inducible
4 Genome Biology Vol 3 No 9 Xie et al.
Figure 2
Chlamydia/host tryptophan cycle. Solid arrows indicate conversion by the enzyme in green on the arrow; dotted arrows show movement across
membranes. Induction of increased levels of tryptophan dioxygenase by IFN- causes flux of the host pool of tryptophan into the kynurenine pathway,
causing starvation of Chlamydia parasites for tryptophan. Starvation for tryptophan presumably derepresses the trpR-regulated operon of tryptophan
biosynthesis (trpBDCEbEa kynU kprS) in C. psittaci. The host-pathway enzymes of interest are located in the cytosol or are located in the mitochondrial
compartment. Genes of tryptophan biosynthesis are named in the order of the pathway steps, following the nomenclature used by Xie et al. [30]. Thus,
trpAa and trpAb (absent in C. psittaci) encode the large (aminase) and small (glutamine-binding) subunits of anthranilate synthase, trpB encodes anthranilate
phosphoribosyl transferase, trpC encodes phosphoribosyl-anthranilate isomerase, trpD encodes indoleglycerol phosphate synthase, and trpEa and trpEb
encode the  and  subunits of tryptophan synthase, respectively. KynU encodes kynureninase. kprS (synonymous with prsA) encodes PRPP synthase.
Orange arrows indicate induction of indoleamine 2,3-dioxygenase and nitric oxide synthase by IFN-. Blue lines indicate inhibition of the latter two
enzymes by nitric oxide and 3-hydroxyanthranilate, respectively.
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in the presence of tryptophan, glucocorticoids and heme
cofactor [17]. In contrast, indoleamine 2,3-dioxygenase has
broad substrate specificity and is capable of depleting low-to-
normal concentrations of tryptophan if induced by IFN-.
The overall host metabolism of tryptophan shown in Figure 2
reflects a general potential that is not necessarily realized in
all cell types. The ultimate catabolic process to generate
acetyl-CoA is a feature of liver and kidney organ systems.
2-Amino-3-carboxymuconate semialdehyde can be consid-
ered to be a branchpoint metabolite that either enters com-
mitted catabolism to acetyl-CoA or that enters biosynthesis to
NAD+/NADP+. In the central nervous system, a number of
kynurenine-pathway metabolites are neuroactive and appear
to be involved in inflammatory neurological diseases [32].
Quinolinate can cause excitotoxic neuronal death. Kynurenic
acid, derived from kynurenine by transamination, can antag-
onize the effect of quinolinate. 3-Hydroxykynurenine and
3-hydroxyanthranilate have been shown to cause apoptotic or
necrotic neuronal death in cell cultures [32]. In glioblastoma
cells (and apparently in human fibroblasts) kynurenine is
an endpoint of tryptophan catabolism [33]. In human
macrophages kynurenine is further metabolized [34].
Indoleamine dioxygenase is a rate-limiting step of tryptophan
catabolism, and other steps are not known to be induced by
IFN-. 3-Hydroxykynurenine is a prominent metabolite in
the eye lens (it absorbs UV radiation) and probably supports
eye pigmentation in the iris/ciliary body [35]. 
Hence, in some host tissue types, kynurenine is a largely
dead-end product of tryptophan catabolism, whereas it has a
variety of metabolic fates in other tissues. In either case,
kynurenine generally exhibits a conspicuous pool size [36].
Thus, although C. psittaci apparently cannot utilize choris-
mate (for which it has an intact biosynthetic pathway) as a
precursor of L-tryptophan, it has the potential to synthesize
its own supply of L-tryptophan from host-generated kynure-
nine, ATP and L-serine. 
It is of interest that the conversion of kynurenine to
anthranilate and the conversion of 3-hydroxykynurenine to
3-hydroxyathranilate are similar hydrolytic reactions. The
host enzyme catalyzing the latter reaction is, in fact, a
kynureninase which is a homolog of the C. psittaci KynU.
Kynureninases have been reported to possess a range of sub-
strate specificities that vary between very high specificity for
kynurenine and very high specificity for 3-hydroxykynure-
nine. The kynureninase of rat and human liver has an order-
of-magnitude preference for 3-hydroxykynurenine [37], in
contrast to a microbial kynureninase that exhibits a very
high preference for kynurenine [38]. It seems likely that the
C. psittaci KynU is specific for kynurenine, whereas the
mammalian host may possess isozymes of different sub-
strate specificity in different tissues.
An intriguing possible layer of additional complexity
involves a competitive relationship between indoleamine
dioxygenase and nitric oxide (NO) synthase (type II
isoform), which are both induced by IFN-. In murine
macrophages, induction of NO synthase requires at least one
additional stimulus (such as bacterial lipopolysaccharide
(LPS)) that acts synergistically with IFN- ([39] and refer-
ences therein). Metabolite flow to NAD+ is proportional to
the input availability of tryptophan in murine macrophages
[40]. Under conditions in which there is induction of both
indoleamine dioxygenase and NO synthase, an interplay of
potential cross-pathway inhibitions are set in motion as
illustrated in Figure 2. Nitric oxide inhibits indoleamine
dioxygenase [41]. On the other hand, 3-hydroxyanthranilate
inhibits both the expression and activity of NO synthase
[39]. Thus, small-molecule products of each pathway can be
mutually inhibitory.
Consider a scenario where C. psittaci has parasitized a host
niche where 3-hydroxyanthranilate is a prominent metabo-
lite, as in human macrophages [42]. The withdrawal of
kynurenine from this flow route might undermine the levels
of 3-hydroxyanthranilate sufficiently to release the restraints
on NO synthase. The consequent increase in nitric oxide
production might then tend to limit the availability of
kynurenine as a result of inhibition of indoleamine dioxyge-
nase. Although this might at first seem an unfavorable
outcome for the C. psittaci parasitism, a finite but minimal
supply of kynurenine might satisfy the highly limited meta-
bolic demands of the persistent state.
Did the C. psittaci trp operon originate by lateral gene
transfer?
The tryptophan operon of C. psittaci is probably derived
from ancestral chlamydial genes before modern events of
gene reduction occurred. However, as the present-day
C. psittaci operon is unique among chlamydiae, it is also
possible that trp genes were lost and then reacquired by
lateral gene transfer (LGT). As this would have happened
recently (after divergence of C. psittaci from other chlamy-
dial lineages), one might then expect the genes to have GC
contents different from that of the overall C. psittaci genome
(42%). Table 1 shows that each operon gene, as well as trpR
and trpEb-2, are within the range expected for C. psittaci.
However, the GC content of the donor genome could have
fortuitously been near that of C. psittaci. If so, one might
expect that the top hits returned from a BLAST search of
each C. psittaci operon gene would not include other
chlamydial genes and would be dominated by one organism
having an appropriate GC content. The results (Table 1)
show that this expectation was not realized.
It is perhaps intriguing that when C. psittaci kynureninase
(KynU) was used as a query sequence, the top hits returned
from BLAST were the KynU orthologs from man and
mouse. Accordingly, the codon usage for the KynU proteins
of C. psittaci and Homo sapiens (left half of Figure 3) was
compared with the genomic codon usage of the respective
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organisms (right half of Figure 3). The codon usage for argi-
nine, leucine, proline and valine is distinctive in a compari-
son of C. psittaci and H. sapiens. The profile of codon usage
for these amino acids by C. psittaci KynU clearly matches
the genomic codon-usage profile of C. psittaci, but not that
of H. sapiens. Thus, there is no evidence for a recent LGT of
kynU between C. psittaci and H. sapiens.
Deterioration of tryptophan-pathway genes in the
chlamydiae 
Chlamydial species have generally undergone reductive evo-
lution that includes an inability to synthesize tryptophan
from chorismate. That the process of reductive evolution is
ongoing is suggested by the variability of remaining rem-
nants and by indications that some of these remnants are
pseudogenes. At one extreme, C. pneumoniae has lost all
tryptophan-pathway genes; C. muridarum has only one
remnant (trpC); and C. trachomatis has three remnants
(trpC, trpEa and trpEb). It appears that C. psittaci alone
assigns a functional role to tryptophan-pathway genes, but it
is a kynurenine-to-tryptophan pathway rather than a choris-
mate-to-tryptophan pathway. Thus, even C. psittaci
is dependent upon host resources (that is, kynurenine)
for tryptophan.
Figure 4 shows a sequence comparison of TrpC from E. coli
with those from chlamydial species. Critical residues can be
assessed with guidance from X-ray crystallography data (see
legend) and invariant residues seen in multiple alignments.
Given the presumed lack of selection for function in C. tra-
chomatis and C. muridarum, it would not be surprising to
find evidence of unfavorable mutations. Indeed, the muta-
tions H335  S335 (E. coli numbering) and G385  E385
in C. trachomatis and C. muridarum, but not in C. psittaci,
probably reflect unfavorable catalytic alterations (see heavy
up arrows in Figure 4). Two changes in C. psittaci, not
present in the other two chlamydial species (V292  T292
and S429  T429) are conservative changes that are pre-
sumably tolerated.
TrpEa from C. trachomatis has clearly accumulated delete-
rious mutations in contrast to the C. psittaci TrpEa
(Figure 5). Comparison of these sequences with that of the
well studied TrpEa from Salmonella typhimurium shows
C. trachomatis TrpEa (but not C. psittaci TrpEa) to have
the following changes at critical residues (S. typhimurium
numbering): G61  N61, G211  R211, F/L212  R212,
and G234  K234. In addition, the intersubunit signaling
residue G181 has been changed to A181 in C. trachomatis.
C. trachomatis TrpEa has a four-residue deletion between
R192 and K193 that is unique in our comprehensive align-
ment of TrpEa. Xie et al. [30] pointed out that the elon-
gated branch of C. trachomatis TrpEa, but not of C. psittaci
TrpEa, on an unrooted phylogenetic tree of the TrpEa
family was consistent with a likely pseudogene status for
the former. The rapid deterioration of TrpEa is, in fact,
apparent from differences in TrpEa from various serovars
of C. trachomatis [43]. Thus, serovar B lacks TrpEa alto-
gether, serovars A and C express severely truncated TrpEa
proteins, whereas serovars D and L2 express full-length
TrpEa proteins (although undoubtedly inactive).
The  subunits of tryptophan synthase in C. psittaci (two
copies, Figure 1) and C. trachomatis appear to have all impor-
tant residues conserved (Figure 6). This includes conserved
catalytic residues and residues that are important for estab-
lishing intersubunit and intrasubunit salt bridges needed for
formation of the - complex of tryptophan synthase. It
6 Genome Biology Vol 3 No 9 Xie et al.
Table 1
Origin of trp-recapture operon by horizontal gene transfer?
First BLAST hit Second BLAST hit
Gene %GC Organism* % Identity Organism* % Identity
trpR 37 Chlamydia trachomatis (42) 61 Vibrio cholerae (48) 37
trpB 40 Arabidopsis thaliana (54) 45 Methanococcus jannaschii (31) 39
trpD 37 Streptomyces coelicolor (72) 43 Mycobacterium leprae (58) 41
trpC 41 Chlamydia trachomatis (42) 47 Chlamydia muridarum (42) 46
trpEb 42 Chlamydia trachomatis (42) 74 Aquifex aeolicus (43) 59
trpEa 39 Chlamydia trachomatis (42) 44 Xylella fastidiosa (54) 40
kynU 40 Homo sapiens (53) 40 Mus musculus (53) 39
kprS 37 Thermotoga maritima (46) 41 Campylobacter jejeuni (31) 41
trpEb-2† 42 Chlamydia trachomatis (42) 69 Pyrococcus kodakaraensis (55) 56
(C. psittaci 42
genome)
*Organisms having proteins returning the top hits after a BLAST search using the indicated C. psittaci genes on the left as query sequences are shown.
Overall genomic %GC is given in parentheses. †Extra-operonic paralog of trpEb (see Figure 1).
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Figure 3
Comparison of codon usage (arginine, leucine, proline and valine) for kynU genes from C. psittaci and H. sapiens with the corresponding whole-genome
codon usages.
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appears that there has been rapid deterioration of TrpEa,
but not of TrpEb. This might suggest that TrpEb is under
positive selection for some functional role other than that of
tryptophan synthase. When TrpEb is not complexed with
TrpEa, it has substantial activity as serine deaminase. There-
fore, present-day TrpEb may function in the chlamydiae as
serine deaminase, as has been proposed by Xie et al. [30] for
some archaea. This is consistent with the total absence of
genes in chlamydiae known to encode enzymes with serine
deaminase activity. These enzymes include Fe-S serine
deaminase (GenBank gi 2501150), PLP-dependent serine
deaminase (gi 134387), catabolic threonine deaminase (gi
135723), and biosynthetic threonine deaminase (gi 135720).
A very recent paper by Fehlner-Gardiner et al. [44] affirms
experimentally the predictions made in this paper that
TrpEb should be functional and TrpEa should not be func-
tional. Fehlner-Gardiner et al. [44] sequenced TrpEa and
TrpEb from all human serovars of C. trachomatis. All of the
genital serovars expressed TrpEa and TrpEb proteins, but
only TrpEb had catalytic activity. Interestingly, the catalytic
indole-utilizing activity of TrpEb required a full-length
TrpEa. It appears that these TrpEa proteins, although
lacking their own catalytic activity, are still functional in
maintaining the TrpEb activity. Even though most of the
ocular serovars also had a potentially functional TrpEb, none
of them would presumably utilize indole in vivo because of
the absence of a full-length TrpEa. The authors propose
that other bacteria in the microenvironment of genital
serovars might be a source of indole, a situation not expected
in the microenvironment of ocular serovars. In short, the
tissue tropism correlates with ability to convert indole to
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Figure 4
Alignment of E. coli (Eco) TrpC from the protein database ( PDB code 1PII) with TrpC proteins from the indicated chlamydiae (Cmu, C. muridarum; Cps,
C. psittaci; Ctr, C. trachomatis). The TrpC domain shown for Eco TrpC is the carboxy-terminal domain of a fusion protein (TrpD•TrpC) whose amino-
terminal domain is TrpD. An extensive multiple alignment of TrpC proteins was carried out, and several potential pseudogenes were excluded. The gaps
shown reflect the gaps required to align the Eco•TrpC with other sequences in the latter alignment (available on request). Invariant residues are
highlighted yellow, and near-invariant (one exception tolerated) residues are shaded gray. Active-site residues are marked with a red triangle and and
residues interacting with ligand with blue dots [60]. See Table 2 for gene identification numbers.
                                         I/V     S/T                      I/V                         G/S
Eco TrpC 259 KVCGLTRGQDAKAAYDAGAIYGGLIFVAT--SPRCVNVEQAQEVMAAAP---LQYVGVFRNHD--IADVV-DKAKVLSLAAVQLHGNEEQL
Cps TrpC   4 KICGVTHPEDAEYAALLGADYIGVIFAEK--SKRKTSLSMAKSIADTTKRLGAEPVGVFVEQT--TDQII-AICEQTGIKTIQLHSTFPLG
Ctr TrpC   4 KICGITHPDDAREAAKAGADYIGMIFAKD--SRRCVSEEKAKYIVEAIQEGNSEPVGVFPEHS--VEEIL-AITETTGITSIQLSGEDILF
Cmu TrpC   4 KICGVTHPDDAWEAAKAGADYVGMIFAKD--SQRCVTKETAKCIVEAIRDGGSEPVGVFSEHS--IGEII-AISSATGITSIQLSGRNIDF
                
Eco TrpC 342 YIDTLREALPAH------VAIWKALSVG---------ETLPAREFQHVDKY-----VL-DNGQ-------GGSGQRFDWSLLNGQSLGNV-
Cps TrpC  90 ALENLLRDYS----------IIYAISVRENGD------VCHPQSLPPKVIP-----LY-DTEK-------GGTGKQFNWKAFSLPKDTFW-
Ctr TrpC  90 KFSQLREHFS----------IFYVVSVYSNGQ-----PSAALPPMNDAVTV-----VY-DHIG-------GERGSPFDWKAFSPFQHNNW-
Cmu TrpC  90 KFSQLRELFS----------IFYVVSVYSNGQ-----PSAAIPPMSNTVTV-----IY-DHIG-------GERGTPFDWRAFSPFQHDNW-
              A/S            L/I/V                     S/T/G      I/V/L
Eco TrpC 404 -------LLAGGLGADNC VEA-AQTG-CAGLDFNSAVESQPGI------KDARLLAS 445/453                   
Residue
interactions
                                                                                 Active sites
Cps TrpC 151 -------MLAGGLNPKNI EEA-VATLHPNGVDVATGVEFPNKTR-----KDPDLLKA 194/206   
Ctr TrpC 152 -------MLGGGVNLWNI KEG-ISLLSPRGIDVSSGVECPGILR-----KDIFLMQA 195/208
Cmu TrpC 152 -------MLGGGVNPGNV GEA-VRLLSPRGIDVSSGVERPGVLR-----KDVTLMQA 195/208
ASI              with ligand
341
89
89
89
403
150
151
151
L-tryptophan in vivo. This seems a reasonable possibility,
although it does not explain why most of the ocular serovars
have maintained a TrpEb that seems to have resisted reduc-
tive evolutionary forces. It would be interesting to know
whether the serine deaminase activity of C. trachomatis
TrpEb (an activity other than indole utilization suggested in
this paper) requires full-length TrpEa or not.
Overview of tryptophan-pathway variability in
chlamydiae 
Shaw et al. [43] have correlated the variability in the number
of tryptophan-pathway enzymes present in chlamydiae (in
particular, the  subunit of tryptophan synthase) with varied
sensitivity to IFN- treatment [16] and ease of demonstrat-
ing the transition to persistence in vitro. C. trachomatis A, B
and C readily develop persistent characteristics following
IFN- treatment. C. pneumoniae also is readily converted to
persistence with IFN- treatment [45]. Tryptophan has been
reported to be essential for growth of serovars A, B and C,
but not for growth of C. psittaci or serovars D-K and L2 of
C. trachomatis [45]. Thus, C. trachomatis serovars A-C, but
not serovars D-K or L1-L3, have been described as ‘trypto-
phan auxotrophs’ [43]. Likewise, C. pneumoniae, but not
C. psittaci, has been described as a tryptophan auxotroph.
Morrison [46] has also discussed the possible relationship
of genes present or absent for tryptophan biosynthesis and
the differential sensitivities of chlamydiae to inhibitory
effects of IFN-. Shaw et al. [43] imply that C. trachomatis
D, L2 and C. psittaci are competent for tryptophan biosyn-
thesis, unlike C. trachomatis A, B, C and C. pneumoniae.
This correlates nicely with proneness to persistence and the
more demonstrable nutritional requirement for tryptophan
in the latter strains, but not the former. However, from the
current database information available, it appears likely
that all chlamydiae, even C. psittaci, are tryptophan aux-
otrophs. As the host itself is incapable of tryptophan biosyn-
thesis, the host is not a credible source of any biosynthetic
intermediates. It is also noteworthy that only C. psittaci has
PRPP synthase, which is needed for provision of PRPP
(TrpB step). Thus, there seems to be no basis for the conclu-
sion [43] that variations in C. trachomatis serovar patho-
genesis can be directly linked to differences in TrpEa, and it
therefore seems that the latter differences are coincidental.
Differential capabilities for acquisition of the host resources
are unknown variables that might distinguish different
strains [47]. In this context, it seems possible that variation
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Figure 5
Alignment of TrpEa from S. typhimurium (Sty) with the TrpEa proteins of C. trachomatis (Ctr) and C. psittaci (Cps). The multiple alignment of numerous
TrpEa proteins performed as described by Xie et al. [30] was used to assess the retention of critical residues by Ctr and Cps. Catalytic residues
established in Sty (see [30]) and conserved throughout the multiple alignment are in blue. Residues interacting with the  subunit are in green. Additional
residues in yellow are invariant. The gaps represent the gaps obtained in the overall multiple alignment (data not shown). Arrows point to probable
inactivating changes in the Ctr sequence. See Table 2 for organism acronyms and gene identification numbers.
Sty TrpEa     1 MERYENLFAQLNDRREGAFVPFVTLGDPG--IEQSLKIIDTLIDAGADALELGVPFSDPLADGPTIQNANLRAFAAGVTPAQCFEMLALIRE----KHPTIPIGLLMYAN 104
Cps TrpEa     1 MNRIETAFKNTK-----PFIGYLTGGDGG--FDYSVACAHALIRGGVDILEIGFPFSDPVADGPIIQKAHTRALEEKTDSTTILEIAKALRE----T-SNIPLVLFSYYN  98
Ctr TrpEa     1 MSKLTQVFKQTK-----LCIGYLTAGDGG--TSYTIEAAKALIQGGVDILELGFPFSDPVADNPEIQVSHDRALAENLTSETLLEIVEGIRA----FNQEVPLILYSYYN  99
Sty TrpEa   105 LVFNNGIDA----FYARCEQVGVDSVLVADVPV----EESAPFRQAALRHNIAPIFICPPNADDDLLRQVASYGRGYTYLLSRSGVTGAENRGAL---P-LHHLIEKLKE 202
Cps TrpEa    99 PLLQKGPQY-----LHQLKAAGFDAVLIVDLPIPQHANESEPFFQALIEAKLFPIVLATPSTREERLLQIRKLAKGFLYYVSQKGTTGIRSKLSD---D-FSTQIARLRC 199
Ctr TrpEa   100 PLLQRDLDY-----LRRLKDAGINGVCVIDLPAPLSHGEKSPFFEDLLAVGLDPILLISAGTTPERMSLIQEYARGFLYYIPCQATRDSEVGIKE---E-FR----KVRE 196
Sty TrpEa   203 YHAA---PALQGFGISSPEQVSAAVRAGAAGAISGSAIVKIIEKNLA----------SPKQMLAE----LRSFVSAMKAASRA---------- 268
Cps TrpEa   200 YFQI---PIVAGFGIANRASAAAALKH-ADGIVVGSAFVEKLEKKI---------------SPEE----LTTFAQSIDPRQ------------ 257
Ctr TrpEa   197 HFDL---PIVDRRDICDKKEAAHVLNY-SDGFIVKTAFVHQTTMDS---------------SVET----LTALAQTVIPG------------- 253
F/Y-22 E-49  D-60
D-56 Salt bridge with β K-167
F/L-212 G-213 S/T-235G-234
    Intersubunit
G-181 signaling
    with β S-178 
Y-175
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Table 2 
Key to sequence identifiers
Genes evaluated Gene-product NCBI GI 
acronym number*
trpC†
Escherichia coli Eco TrpC 16129223
Chlamydia trachomatis D Ctra TrpC 7227938
Chlamydia muridarum Cmu TrpC 8163265
Chlamydophila psittaci Cpsi TrpC N/A
Pseudomonas aeruginosa Pae TrpC 15598309
Neisseria gonorrhoeae Ngo TrpC N/A
Neisseria meningitidis Nme TrpC 15793859
Nitrosomonas europaea Neu TrpC N/A
Bordetella pertussis Bpe TrpC N/A
Bordetella bronchiseptica Bbr TrpC N/A
Xylella fastidiosa Xfa TrpC 15837975
Thermotoga maritima Tma TrpC 15642913
Rhodobacter capsulatus Rca TrpC N/A
Streptococcus mutans Smu TrpC N/A
Aquifex aeolicus Aae TrpC 15607040
Chlorobium tepidum Cte TrpC N/A
Nostoc punctiforme Npu TrpC N/A
Streptococcus pneumoniae Spn TrpC 15901642
Anabaena sp. Ana TrpC N/A
Clostridium acetobutylicum Cac TrpC 15896407
Rhodopseudomonas palustris Rpa TrpC N/A
Synechocystis sp. Syn TrpC 16331130
Haemophilus influenzae Hin TrpC 16273300
Salmonella typhimurium Sty TrpC 16765069
Bacillus stearothermophilus Bst TrpC N/A
Yersinia pestis Ype TrpC 16122433
Vibrio cholerae Vch TrpC 15641184
Pasteurella multocida Pmu TrpC 15602445
Yersinia pseudotuberculosis Yps TrpC N/A
Deinococcus radiodurans Dra TrpC 15805163
Bacillus subtilis Bsu TrpC 421536
Escherichia coli Eco TrpC 16129223
Helicobacter pylori Hpy TrpC 15645893
Staphylococcus aureus Sau TrpC 15924361
Bacillus halodurans Bha TrpC 15614225
Synechococcus sp. Ssp. TrpC N/A
Prochlorococcus marinus Pma TrpC N/A
Chlamydia trachomatis Ctr TrpC 15605050
Chlamydia muridarum Cmu TrpC 15835220
Corynebacterium diphtheriae Cdi TrpC N/A
Methanococcus jannaschii Mja TrpC 15668627
Pyrococcus furiosus Pfu TrpC 18978079
Archaeoglobus fulgidus Afu TrpC 11499194
Pyrococcus abyssii Pab TrpC N/A
Methanobacterium Mth TrpC 136346
thermoautotrophicum
Methanococcus maripaludis Mma TrpC N/A
Table 2 (continued)
Genes evaluated Gene-product NCBI GI 
acronym number*
Ferroplasma acidarmanus Fac TrpC N/A
Saccharomyces cerevisiae Sce TrpC 6320210
Arabidopsis thaliana Ath TrpC 5031254
trpEa‡
Salmonella typhimurium Sty TrpEa 16765071
Chlamydia trachomatis D Ctra TrpEa 15604890
Chlamydophila psittaci Cpsi TrpEa N/A
trpEb§
Salmonella typhimurium Sty TrpEb 136281
Chlamydia trachomatis D Ctra TrpEb 15604889
Chlamydia psittaci Cpsi TrpEb1 N/A
Chlamydia psittaci Cpsi TrpEb2 N/A
Homologs of E. coli TyrP, Mtr and TnaB (Figure 7)
Chlamydophila psittaci Cpsi N/A
Chlamydophila pneumoniae Cpn-1 15618876
CWL029
Chlamydophila pneumoniae Cpn-2 15618878
CWL029
Chlamydia muridarum Cmu-1 15834824
Chlamydia muridarum Cmu-2 15834825
Chlamydia trachomatis D Ctr-1 15605552
Chlamydia trachomatis D Ctr-2 15605553
Haemophilus ducreyi Hdu-1 N/A
Haemophilus ducreyi Hdu-2 N/A
Haemophilus ducreyi Hdu-3 N/A
Nostoc punctiforme Npu N/A
Haemophilus influenzae Hin-1 16272242
Haemophilus influenzae Hin-2 16272424
Haemophilus influenzae Hin-3 16272472
Pasteurella multocida Pmu-1 15602597
Pasteurella multocida Pmu-2 15603057
Pasteurella multocida Pmu-3 15602675
Pasteurella multocida Pmu-4 15603284
Vibrio cholerae Vch-1 15601527
Vibrio cholerae Vch-2 15600930
Escherichia coli TyrP 16129857
Escherichia coli Mtr 16131053
Escherichia coli TnaB 16131577
Yersinia pestis Ype-1 16121500
Yersinia pestis Ype-2 16121568
Salmonella typhi Sty-1 16760884
Salmonella typhi Sty-2 16762044
Neisseria meningitidis Nme 15677855
Pseudomonas aeruginosa Pae-1 15600627 
Pseudomonas aeruginosa Pae-2 15597112
Pseudomonas aeruginosa Pae-3 15598961
Neisseria gonorrhoeae Ngo N/A 
in LifA integrity or copy number could easily explain varia-
tion in IFN- sensitivity and the nutritional requirement for
L-tryptophan in vitro.
Except for C. psittaci, we may be seeing different strains in
varied states of reductive evolution with respect to what
remnants of genes for tryptophan biosynthesis remain.
C. pneumoniae and C. trachomatis B lack genes encoding
the entire tryptophan pathway. C. trachomatis D possesses
trpC, trpEa and trpEb; C. muridarum possesses only trpC;
C. trachomatis A and C possess trpEa and trpEb. The trun-
cation of trpEa in C. trachomatis A and C, the likely pseudo-
gene status of trpEa in serovar D, and the absence of trpEa
altogether in serovar B indicates an active ongoing process of
reductive evolution.
Chlamydial transport of tryptophan, kynurenine and
serine 
The chlamydiae are dependent on host cells for a variety of
metabolites that are relevant to the host-parasite relation-
ships of tryptophan metabolism. These include kynurenine,
serine, ATP and tryptophan itself. Hence, the nature and
variability for transport of these compounds should be of
considerable interest. 
Species of chlamydiae possess one (C. psittaci) or two
(C. muridarum, C. trachomatis and C. pneumoniae)
homologs of genes encoding the well characterized
hydroxy/aromatic amino acid (HAAAP) permease family
[48]. Figure 7 presents an unrooted radial tree that shows
the chlamydial proteins to comprise a distinct cluster. E. coli
Mtr (high-affinity tryptophan permease) and TnaB (low-
affinity tryptophan permease) comprise one distinct group,
and E. coli TyrP homologs make up another distinct group.
The chlamydial sequences are approximately equidistant
from the TyrP/Mtr-TnaB groupings. These chlamydial pro-
teins might be broad-specificity transporters of tryptophan,
tyrosine, phenylalanine and perhaps kynurenine as well. 
When the Na+-coupled serine symporter SdaC from E. coli
was used as a query against the chlamydial genomes, TyrP
was the top hit (22% identity). This reflects the membership
of SdaC proteins in the HAAAP family. An alternative query,
the E. coli CycA serine/alanine/glycine transporter, yielded
CT216 as the top hit (only 22% identity). E. coli possesses a
Na+-coupled serine symporter, SttT, which is regulated by
tryptophan [49]. Although this is but one of at least five dif-
ferent transporters for serine in E. coli, sstT encodes the sole
serine/threonine transporter in Porphyromonas gingivalis
[50]. Species of chlamydiae possess two paralogs of SstT,
which were judged to be the most likely genes encoding
serine transport. Perhaps one favors serine transport and
the other threonine transport. Figure 8 shows an unrooted
tree of SstT proteins.
The tryptophan repressor 
The presence of trpR implies that the tryptophan operon is
under repression control by L-tryptophan, and some experi-
mental evidence does indeed show derepression under con-
ditions of tryptophan limitation [43]. Starvation for
host-derived L-tryptophan, which is initiated by induction of
indoleamine dioxygenase by IFN-, undoubtedly triggers
derepression of the entire tryptophan operon, including the
genes encoding PRPP synthase and kynureninase. Kynureni-
nase from C. psittaci is a key linker between the anthrani-
late-utilizing TrpB enzyme that initiates tryptophan
biosynthesis in the parasite and the host kynurenine forami-
dase that generates kynurenine. In effect a hybrid host-
parasite cycle is generated in which a metabolic stream in
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Table 2 (continued)
Genes evaluated Gene-product NCBI GI 
acronym number*
Homologs of E. coli SstT and Pgin SstT (Figure 8)
Chlamydia trachomatis (Group A) Ctra gil15605126
Chlamydia muridarum (Group A) Cmu gil15835296
Chlamydophila pneumoniae Cpn gil15618439
(Group A)
Chlamydia trachomatis (Group B) Ctra gil15604951
Chlamydia muridarum (Group B) Cmu gil15835119
Chlamydophila pneumoniae Cpn gil15618209
(Group B)
Porphyromonas gingivalis Pgin N/A
Corynebacterium diphtheriae Cdip N/A
Clostridium difficile Cdi N/A
Treponema pallidum Tpa gil15639544
Vibrio cholerae Vch gil15600807
Pseudomonas aeruginosa Pae gil15597238
Yersinia pestis Ype gil16120913
Escherichia coli Eco gil16130984
Yersinia pseudotuberculosis Ype N/A
Campylobacter jejuni Cje gil15792422
Haemophilus influenzae Hin gil16273445
Pasteurella multocida Pmu gil15602756
Neisseria meningitidis Nme gil15793312
Neisseria gonorrhoeae Ngo N/A
Haemophilus ducreyi Hdu N/A
Enterococcus faecium Efa N/A
Streptococcus pyogenes Spy gil15674487
Streptococcus pneumoniae Spn gil15903640
Streptococcus equi Seq N/A
*N/A applies to genes not yet included in the NCBI database. †Includes in
addition to identifiers of the four sequences shown in Figure 4, the
sequence identifiers for the sequences used in the multiple alignment that
supports the gaps and conserved residues indicated on line 1 of Figure 4.
‡See [30] for the sequence identifiers used in the multiple alignment
which supports the gaps and conserved residues indicated on line 1 of
Figure 5. §See [29] for the sequence identifiers used in the multiple
alignment which support the gaps and conserved residues indicated on
line 1 of Figure 6.
the host away from tryptophan is intercepted by a metabolic
stream toward tryptophan in C. psittaci. 
The thoroughly studied repressor protein that regulates
tryptophan biosynthesis in E. coli is of limited phylogenetic
distribution. In fact, Xylella fastidiosa, C. trachomatis and
C. psittaci are the only organisms outside the enteric lineage
known to possess trpR. The GC content of trpR was exam-
ined for evidence of possible horizontal transfer. Table 3 lists
the GC content of trpR genes, compared to the GC content of
the corresponding genomes. The trpR GC content of each
organism corresponded relatively well to the genomic GC
content, except for X. fastidiosa where trpR exhibited a low
GC content, more similar to that of the chlamydiae or
H. influenzae.
Does C. psittaci have a regulon controlled by trpR?
In E. coli the trp repressor binds upstream of the trp operon
and upstream at the mtr transport gene in promoter regions
where CTCG or CTAG are important for binding [51]. The
sstT gene of E. coli is also subject to repression control by
tryptophan and a CTCG upstream region has been proposed
to be an additional target region for TrpR [49].
As C. psittaci has trpR, it seems quite possible that the trp
operon, sstT (for serine transport), and tyrP (for tryptophan
12 Genome Biology Vol 3 No 9 Xie et al.
Figure 6
Alignment of TrpEb from S. typhimurium (Sty) with the TrpEb proteins from C. trachomatis (Ctr) and C. psittaci (Cps). Cps TrpEb1 is the paralog within the
operon shown in Figure 1. Residues in the Sty sequence that are invariant in an extensive multiple alignment are marked in yellow and near-invariant
residues are shaded in gray. Substrate, cofactor and metal-coordinating residues are color-coded as indicated by the key at bottom right. The movable
COMM domain that interacts with the  subunit is marked, as well as residues K167 and S178 (not conserved) which contact the indicated residues of
the  subunit. Residues critical for formation of internal salt bridges are also shown. See Xie et al. [30] for a detailed analysis. See Table 2 for organism
acronyms and gene identification numbers.
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transport) might comprise a regulon controlled by the trpR
repressor. Indeed, CTAG and/or CTCG motifs were found
upstream of all these genes in C. psittaci, but the presence of
these regions did not exceed random probability sufficiently
to justify any concrete assertions. The further use of a com-
putational approach [52] to identify the transcription regula-
tory pattern was also not illuminating. As chlamydial TrpR
proteins are the most divergent of TrpR proteins, the motif
pattern for DNA binding may also be divergent.
Conclusions 
Chlamydial parasites appear to respond to host mechanisms
for restriction of tryptophan availability with a diversity of
strategies, the exact nature of which we still know very little.
One strategy utilized by C. muridarum employs a three-copy
dose of lifA, which could inhibit cytokine proliferation and
decrease IFN- production by the host (although at least some
IFN- has been shown to be produced in mice infected with
C. muridarum [53]). Such a strategy would seem to be consis-
tent with acute infections, which can be a successful mode of
pathogenicity in some situations, such as high-density rodent
populations. In the case of C. muridarum, the mechanism
does not necessarily involve blocking the induction of
indoleamine dioxygenase and thereby preventing depletion of
host tryptophan, in view of some experimental work with the
MoPn/mouse model system. The primary effect of the IFN-
may not be to cause starvation for tryptophan as anti-
chlamydial and anti-proliferative activities of murine IFN-
in mouse cells was not reversible by tryptophan [54]. It has
been concluded in other studies as well [55,56] that host-
mediated tryptophan depletion is not an important factor in
the MoPn/mouse model system. However, a conflicting con-
clusion was recently published by Perfettini et al. [57] that the
inhibitory effect of IFN- in mouse cell cultures and genital
tracts seems to be due in part to tryptophan depletion
(because inhibition was partially reversed by tryptophan). It
has been generally observed that in murine systems
indoleamine dioxygenase has not been induced by IFN-
under the same experimental conditions that readily induce
synthesis of the enzyme in human systems. However, the
potential to induce the dioxygenase in murine systems by
IFN- exposure has been demonstrated when nitric oxide pro-
duction is blocked [41]. Thus, it seems that the key difference
between the mouse and human systems might lie in the details
that dictate the balance between the cross-regulated pathways
of tryptophan and arginine metabolism (see Figure 2). If so, in
human systems the balance favors domination by the
indoleamine dioxygenase route, whereas in murine systems
the nitric oxide route is favored. Many individual factors could
influence the balance, including differential sensitivities of NO
synthase to inhibition by 3-hydroxyanthranilate or of
indoleamine dioxygenase to inhibition by nitric oxide. In addi-
tion, unidentified cytokine-mediated mechanisms undoubt-
edly await elucidation. 
In any event, for most chlamydiae the successful implemen-
tation of tryptophan depletion by the host is closely tied to
chlamydial responses that result in a persistent metabolic
state and chronic disease. It would appear that chlamydiae
have learned to recognize and exploit tryptophan depletion
as an environmental cue that initiates a distinct chain of
remodeling biochemistry that promotes long-term viability
in a latent state.
It is difficult to guess whether the ability of C. psittaci to scav-
enge kynurenine as a source of tryptophan is a recent innova-
tion in this lineage, or whether it represents an ancient
chlamydial strategy that has been abandoned by other
chlamydiae. Perhaps the strategy is linked to the particular
tissue tropism of C. psittaci. Because the presence of the tryp-
tophan-pathway enzymes varies so markedly, even between
closely related stains, one cannot be certain at this point that
the tryptophan-recapture cycle is uniquely characteristic of
C. psittaci. It cannot be ruled out that other strains of
C. psittaci might lack the cycle, whereas some strains of C. tra-
chomatis or C. pneumoniae not yet sequenced might possess
it. Different overall host metabolism and different biochemical
environments in various tissues undoubtedly influence the
availability of kynurenine (as well as other metabolites such as
ATP and serine). Hence, tissue tropism must be a crucial
factor. It would be interesting to know whether the trypto-
phan-recapture cycle is capable of providing abundant trypto-
phan to the parasite, or whether it might be more subtly
geared to provision of barely adequate tryptophan for para-
sites established in the chronic-infection mode.
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Table 3
GC content of trpR genes compared to the GC content of the
corresponding genomes
%GC
Organism Genome trpR
Chlamydia psittaci 42 37
Chlamydia trachomatis D 42 37
Escherichia coli 51 54
Salmonella typhimurium 55 54
Haemophilus influenzae 38 36
Vibrio cholerae 48 50
Enterobacter aerogenes 61 58
Yersinia pestis 50 51
Yersinia pseudotuberculosis 43 50
Pasteurella multocida 38 43
Actinobacillus actinomycetemcomitans 39 44
Xylella fastidiosa* 54 34
Enterobacter cloacae 56 58
*trpR from X. fastidiosa has been found to be part of a low-GC block of
genes, for which there is strong evidence for lateral gene transfer (G.X.,
C.A.B., N. Keyhani, and R.A.J., unpublished observations).
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Figure 7
Unrooted phylogenetic tree (radial view) of the TyrP family of transport proteins. A multiple alignment was obtained by input of the indicated sequences
into the ClustalW program (version 1.4). Manual alignment adjustments were made with the assistance of the BioEdit multiple alignment tool of Hall [61].
The refined multiple alignment was used as input for generation of a phylogenetic tree using the program packages PHYLIP [62] and PHYLO_WIN [63].
The neigbor-joining and Fitch programs were used to obtain distance-based trees. The distance matrix was obtained using Protdist with a Dayhoff PAM
matrix. The Seqboot and Consense programs were then used to assess the statistical strength of the tree using bootstrap resampling. Neighbor-joining
(shown) and Fitch trees yielded similar clusters and arrangement of taxa within them. Bootstrap values of 1,000 per 1,000 iterations (indicated with blue
circles) supported the major nodes, one of which contains all of the chlamydial proteins. The experimentally documented E. coli proteins TyrP (tyrosine
transport), Mtr (high-affinity tryptophan transport) and TraB (low-affinity tryptophan transport) are highlighted in yellow. See Table 2 for organism
acronyms and gene identification numbers. In contrast to the two paralogs of tyrP present in C. pneumoniae CWLO29, as shown, some intra-species
variation occurs in that C. pneumoniae J138 has only a single tyrP gene, and a small hypothetical gene is inserted between the two paralog tyrP genes of
C. pneumoniae AR39.
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